Portuguese pharma firm says best practice followed in French drug trial
Lisbon (AFP) – Portuguese pharmaceutical company Bial insisted Friday that it had followed “international best practice†in a French drugs trial that has left one person brain-dead and five others hospitalised.
The company said in a statement it had followed “the applicable legislation†and that it would cooperate with the investigation underway to “determine in a rigorous and exhaustive manner†what happened.